  Introduction: Topical intranasal drugs are widely prescribed for Chronic
Rhinosinusitis (CRS), although delivery can vary with device type and droplet
size. The study objective was to compare nebulized and sprayed droplet
deposition in the paranasal sinuses and ostiomeatal complex (OMC) across
multiple droplet sizes in CRS patients using computational fluid dynamics
(CFD). Methods: Three-dimensional models of sinonasal cavities were constructed
from computed tomography (CT) scans of three subjects with CRS refractory to
medical therapy using imaging software. Assuming steady-state inspiratory
airflow at resting rate, CFD was used to simulate 1-120 {\mu}m sprayed droplet
deposition in the left and right sinuses and OMC with spray nozzle positioning
as in current nasal spray use instructions. Zero-velocity nebulization
simulations were performed for 1-30 {\mu}m droplet sizes, maximal sinus and OMC
deposition fractions (MSDF) were obtained, and sizes that achieved at least 50%
of MSDF were identified. Nebulized MSDF was compared to sprayed droplet
deposition. We also validated CFD framework through in vitro experiments.
Results: Among nebulized droplet sizes, 11-14 {\mu}m droplets achieved at least
50% of MSDF in all six sinonasal cavities. Five of six sinonasal cavities had
greater sinus and OMC deposition with nebulized droplets than with sprayed
droplets at optimal sizes. Conclusions: Nebulized droplets may target the
sinuses and OMC more effectively than sprayed particles at sizes achieving best
deposition. Further studies are needed to confirm our preliminary findings.
Several commercial nasal nebulizers have average particle sizes outside the
optimal nebulized droplet size range found here, suggesting potential for
product enhancement.
